Addolorato, G., Leggio, L., Ferrulli, A., Cardone, S., Vonghia, L., Mirijello, A., … Gasbarrini, G. (2007). Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: Randomised, double-blind controlled study. Lancet, 370(9603), 1915–1922.CrossRefGoogle ScholarPubMed

Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R.A., Couper, D., Donovan, D.M., … COMBINE Study Research Group. (2006). Combined pharmacotherapies and behavioural interventions for alcohol dependence. Journal of the American Medical Association, 295, 2003–2017.Google Scholar

Azrin, N. H. (1976). Improvements in the community-reinforcement approach to alcoholism. Behaviour Research and Therapy, 14, 339–348.CrossRefGoogle ScholarPubMed

Azrin, N. H., Sisson, R. W., Meyers, R., & Godley, M. (1982). Alcoholism treatment by disulfiram and community reinforcement therapy. Journal of Behaviour Therapy and Experimental Psychiatry, 13, 105–112.CrossRefGoogle ScholarPubMed

Baker, J. R., Jatlow, P. M., & McCance-Katz, E. F. (2007), Disulfiram effects on responses to intravenous cocaine administration. Drug and Alcohol Dependence, 87, 202–209.CrossRefGoogle ScholarPubMed

Berglund, M., Thelander, S., & Jonsson, E. (2003). Treating alcohol and drug abuse: An evidence-based review. Weinheim, Germany: Wiley-VCH.Google Scholar

Blodgett, J. C., Del Re, A. C., Maisel, N. C., & Finney, J. W. (2014). A meta-analysis of topiramate’s effects for individuals with alcohol use disorders. Alcoholism: Clinical and Experimental Research, 38(6), 1481–1488.CrossRefGoogle ScholarPubMed

Bogenschutz, M. P., Scott Tonigan, J., & Pettinati, H. M. (2009). Effects of alcoholism typology on response to naltrexone in the COMBINE study. Alcoholism: Clinical and Experimental Research, 33(1), 10–18.CrossRefGoogle ScholarPubMed

Bowen, S., Witkiewitz, K., Clifasefi, S. L., Grow, J., Chawla, N., Hsu, S. H., … Larimer, M. E. (2014). Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: A randomized clinical trial. JAMA Psychiatry, 71(5), 547–556.Google Scholar

Carroll, K. M., Nich, C., Ball, S. A., McCance, E., Frankforter, T. L., & Rounsaville, B. J. (2000). One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: Sustained effects of treatment. Addiction, 95, 1335–1349.Google Scholar

Chick, J., Howlett, H., Morgan, M. Y., & Ritson, B. (2000). United Kingdom Multicentre Acamprosate Study (UKMAS): A 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol and Alcoholism, 35(2), 176–187.CrossRefGoogle ScholarPubMed

Conklin, C. A., & Tiffany, S. T. (2002). Applying extinction research and theory to cue-exposure addiction treatments. Addiction, 97(2), 155–67.CrossRefGoogle ScholarPubMed

Copello, A., Orford, J., Hodgson, R., Tober, G., & Barrett, C. (2002). Social behaviour and network therapy: Basic principles and early experiences. Addictive Behaviours, 27, 354–366.CrossRefGoogle ScholarPubMed

Copello, A. G., Hodgson, R., Tober, G., & Orford, J. (2009). Social behaviour and network therapy for alcohol problems. London: Routledge.Google Scholar

Copello, A. G., Velleman, R. D., & Templeton, L. (2005). Family interventions in the treatment of alcohol and drug problems. Drug and Alcohol Review, 24, 369–385.CrossRefGoogle ScholarPubMed

De Sousa, A., & De Sousa, A. (2004). A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence. Alcohol and Alcoholism, 39(6), 528–531.Google Scholar

De Sousa, A., & De Sousa, A. (2005). An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence. Alcohol and Alcoholism, 40(6), 545–548.CrossRefGoogle ScholarPubMed

Donoghue, K., Elzerbi, C., Saunders, R., Whittington, C., Pilling, S., & Drummond, C. (2015). The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence, Europe versus the rest of the world: A meta-analysis. Addiction, 110(6), 920–930.Google Scholar

Donovan, D. M., Anton, R. F., Miller, W. R., Longabaugh, R., Hosking, J. D., Youngblood, M., & COMBINE Study Research Group. (2008). Combined pharmacotherapies and behavioral interventions for alcohol dependence (The COMBINE Study): Examination of posttreatment drinking outcomes. Journal of Studies on Alcohol and Drugs, 69(1), 5–13.CrossRefGoogle ScholarPubMed

Drummond, D. C., Tiffany, S. T., Glautier, S., & Remington, B. (1995). Addictive behaviour: Cue exposure, theory and practice. Chichester, UK: John Wiley & Sons.Google Scholar

Foxcroft, D. R., Coombes, L., Wood, S., Allen, D., & Almeida Santimano, N. M. (2014). Motivational interviewing for alcohol misuse in young adults. Cochrane Database of Systematic Reviews, CD007025.Google Scholar

Fuller, R. K., Branchley, L., Brightwell, D. R., Derman, R. M., Emrick, C. D., Iber, F. L., … Shaw, S. (1986). Disulfiram treatment of alcoholism: A Veterans Administration cooperative study. Journal of the American Medical Association, 256, 1449–1455.Google Scholar

Garbutt, J. C., Kampov-Polevoy, A. B., Gallop, R., Kalka-Juhl, L., & Flannery, B. A. (2010). Efficacy and safety of baclofen for alcohol dependence: A randomized, double-blind, placebo-controlled trial. Alcoholism: Clinical and Experimental Research, 34(11), 1849–1857.Google Scholar

Garbutt, J. C., Kranzler, H. R., O’Malley, S. S., Gastfriend, D. R., Pettinati, H. M., Silverman, B. L., … Vivitrex Study Group. (2005). Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: A randomized controlled trial. Journal of the American Medical Association, 293, 1617–1625.CrossRefGoogle ScholarPubMed

Garbutt, J. C., West, S. L., Carey, T. S., Lohr, K. N., & Crews, F. T. (1999). Pharmacological treatment of alcohol dependence: A review of the evidence. Journal of the American Medical Association, 281, 1318–1325.CrossRefGoogle ScholarPubMed

Gual, A., He, Y., Torup, L., van den Brink, W., Mann, K., & ESENSE 2 Study Group. (2013). A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence. European Neuropsychopharmacology, 23(11), 1432–1442.Google Scholar

Gueorguieva, R., Wu, R., Tsai, W. M., O’Connor, P. G., Fucito, L., Zhang, H., & O’Malley, S. S. (2015). An analysis of moderators in the COMBINE study: Identifying subgroups of patients who benefit from acamprosate. European Neuropsychopharmacology. Advance online publication. http://dx.doi.org/10.1016/j.euroneuro.2015.06.006CrossRefGoogle Scholar

Guglielmo, R., Martinotti, G., Clerici, M., & Janiri, L. (2012). Pregabalin for alcohol dependence: A critical review of the literature. Advances in Therapy, 29(11), 947–957.Google Scholar

Haber, P., Lintzeris, N., Proude, E., & Lopatko, O. (2009). Guidelines for the treatment of alcohol problems. Sydney: Australian Government Department of Health and Ageing.Google Scholar

Haug, N. A., Duffy, M., & McCaul, M. E. (2014). Substance abuse treatment services for pregnant women: Psychosocial and behavioral approaches. Obstetrics and Gynecology Clinics of North America, 41(2), 267–296.CrossRefGoogle ScholarPubMed

Heinälä, P., Alho, H., Kiianmaa, K., Lönnqvist, J., Kuoppasalmi, K., & Sinclair, J. D. (2001). Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: A factorial double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology, 21(3), 287–292.Google Scholar

Hester, R. K. (1995). Behavioural self control training. In Hester, R. K. & Miller, W. R. (Eds.), Handbook of alcoholism treatment approaches: Effective alternatives (2nd ed., pp. 148–159). Needham Heights, MS: Allyn and Bacon.Google Scholar

Holder, H., Longabaugh, R., Miller, W. R., & Rubonis, A. V. (1991). The cost effectiveness of treatment for alcoholism: A first approximation. Journal of Studies on Alcohol, 52, 517–540.Google Scholar

Hughes, J. L., & Cook, C. C. H. (1997). The efficacy of disulfiram: A review of outcome studies. Addiction, 92, 381–396.Google Scholar

Hunt, G. M., & Azrin, N. H. (1973). A community-reinforcement approach to alcoholism. Behaviour Research and Therapy, 11, 91–104.Google Scholar

Iovieno, N., Tedeschini, E., Bentley, K. H., Evins, A. E., & Papakostas, G. I. (2011). Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: A meta-analysis of placebo-controlled randomized trials. Journal of Clinical Psychiatry, 72(8), 1144–1151.Google Scholar

Jarvis, T. J., Tebbutt, J., Mattick, R. P., & Shand, F. (2005). Treatment approaches for alcohol and drug dependence: An introductory guide (2nd ed.). Chichester, UK: John Wiley & Sons.Google Scholar

Jonas, D. E., Amick, H. R., Feltner, C., Bobashev, G., Thomas, K., Wines, R., … Garbutt, J. C. (2014). Pharmacotherapy for adults with alcohol use disorders in outpatient settings: A systematic review and meta-analysis. Journal of the American Medical Association, 311(18), 1889–1900.Google Scholar

Kalk, N. J., & Lingford-Hughes, A. R. (2014). The clinical pharmacology of acamprosate. British Journal of Clinical Pharmacology, 77(2), 315–323.Google Scholar

Kelly, J. F., Humphreys, K., & Ferri, M. (in press). Alcoholics Anonymous and twelve-step treatments for alcohol use disorder. Cochrane Database of Systematic Reviews.Google Scholar

Kiefer, F., Jahn, H., Tarnaske, T., Helwig, H., Briken, P., Holzbach, R., … Wiedemann, K. (2003). Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: A double-blind, placebo-controlled study. Archives of General Psychiatry, 60(1), 92–99.CrossRefGoogle ScholarPubMed

Kohler, S., & Hofmann, A. (2015). Can motivational interviewing in emergency care reduce alcohol consumption in young people? A systematic review and meta-analysis. Alcohol and Alcoholism, 50(2), 107–117.Google Scholar

Kragh, H. (2008). From disulfiram to antabuse: The invention of a drug. Bulletin for the History of Chemistry, 33, 82–88.Google Scholar

Kranzler, H. R., Tennen, H., Armeli, S., Chan, G., Covault, J., Arias, A., & Oncken, C. (2009). Targeted naltrexone for problem drinkers. Journal of Clinical Psychopharmacology, 29(4), 350.CrossRefGoogle ScholarPubMed

Krupitsky, E., Zvartau, E., Blokhina, E., Verbitskaya, E., Wahlgren, V., Tsoy-Podosenin, M., … Woody, G. E. (2012). Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence. Archives of General Psychiatry, 69(9), 973–981.Google Scholar

Laaksonen, E., Koski-Jännes, A., Salaspuro, M., Ahtinen, H., & Alho, H. (2008). A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence. Alcohol and Alcoholism, 43(1), 53–61.Google Scholar

Leung, J. G., Hall-Flavin, D., Nelson, S., Schmidt, K. A., & Schak, K. M. (2015). The role of gabapentin in the management of alcohol withdrawal and dependence. Annals of Pharmacotherapy. Advance online publication. doi:10.1177/1060028015585849Google Scholar

Lingford-Hughes, A. R., Welch, S., Peters, L., & Nutt, D. J. (2012). BAP updated guidelines: Evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: Recommendations from BAP. Journal of Psychopharmacology, 26(7), 899–952.Google Scholar

Ludwig, D. S., & Kabat-Zinn, J. (2008). Mindfulness in medicine. Journal of the American Medical Association, 300(11), 1350–1352.Google Scholar

Maisel, N. C., Blodgett, J., Wilbourne, P. L., Humphreys, K., & Finney, J. W. (2013). Meta-analysis of naltrexone and acamprosate for treating alcohol dependence: When and for what are these medications most helpful? Addiction, 108, 275–293.CrossRefGoogle Scholar

Management of Substance Use Disorders Workgroup. (2009). VA/DOD clinical practice guideline for the management of substance abuse disorders. Washington, DC: Departments of Defense and Veterans Affairs.Google Scholar

Mann, K., Bladström, A., Torup, L., Gual, A., & van den Brink, W. (2013). Extending the treatment options in alcohol dependence: A randomized controlled study of as-needed nalmefene. Biological Psychiatry, 73(8), 706–713.Google Scholar

Mann, K., Lemenager, T., Hoffmann, S., Reinhard, I., Hermann, D., Batra, A., … PREDICT Study Team (2013). Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study. Addiction Biology, 18(6), 937–946.CrossRefGoogle ScholarPubMed

Marlatt, G. A., & Gordon, J. R. (1985). Relapse prevention. New York: Guilford.Google Scholar

Martin, B., Clapp, L., Bialkowski, D., Bridgeford, D., Amponsah, A., Lyons, L., & Beresford, T. P. (2003). Compliance to supervised disulfiram therapy: A comparison of voluntary and court-ordered patients. American Journal of Addictions, 12, 137–143.Google Scholar

Meyers, R. J., & Miller, W. R. (2001). A community reinforcement approach to addiction treatment. Cambridge, UK: Cambridge University Press.Google Scholar

Meyers, R. J., Smith, J. E., Serna, B., & Belon, K. E. (2013). Community reinforcement approaches: CRA and CRAFT. In Miller, P. (Ed.), Interventions for addiction: Comprehensive addictive behaviors and disorders (pp. 47–56). San Diego, CA: Academic Press.Google Scholar

Miller, W. R., Andrews, N. R., Wilbourne, P., & Bennett, M. E. (1998). A wealth of alternatives: Effective treatments for alcohol problems. In Miller, W. R. & Heather, N., eds., Treating Addictive Behaviours (2nd ed., pp. 203–216). New York: Plenum.Google Scholar

Miller, W. R., & Rollnick, S. (2002). Motivational interviewing: Preparing people for change. New York: Guilford.Google Scholar

Miller, W. R., Walters, S. T., & Bennett, M. E. (2001). How effective is alcoholism treatment in the United States. Journal of Studies on Alcohol, 62, 211–220.Google Scholar

Miller, W. R., Wilbourne, P. D., & Hetema, J. E. (2003). What works? A summary of alcohol treatment outcome research. In Hester, R. K. & Miller, W. R. (Eds.), Handbook of alcoholism treatment approaches: Effective alternatives (3rd ed, pp. 13–63). Boston, MA: Allyn and Bacon.Google Scholar

Monti, P. M., Abrams, D. B., Binkoff, J. A., Zwick, W. R., Liepman, M. R., Nirenberg, T. D., & Rohsenow, D. J. (1990). Communication skills training, communication skills training with family and cognitive behavioural mood management training for alcoholics. Journal of Studies on Alcohol, 51, 263–270.CrossRefGoogle ScholarPubMed

Monti, P. M., Rohsenhow, D. J., Colby, S. M., & Abrams, D. B. (1995). Coping and social skills training. In Hester, R. K. & Miller, W. R. (Eds.), Handbook of alcoholism treatment approaches: Effective alternatives (2nd ed., pp. 221–241). Needham Heights, MS: Allyn and Bacon.Google Scholar

Monti, P. M., Rohsenhow, D. J., Rubonis, A. V., Niaura, R. S., Sirota, A. D., Colby, S. M., … Abrams, D. B. (1993). Cue exposure with coping skills treatment for male alcoholics: A preliminary investigation. Journal of Consulting and Clinical Psychology, 61, 1011–1019.CrossRefGoogle ScholarPubMed

Moos, R. H. (2005). Iatrogenic effects of psychosocial interventions for substance use disorder: Prevalence, predictors, prevention. Addiction, 100, 595–604.Google Scholar

Morley, K. C., Teesson, M., Reid, S. C., Sannibale, C., Thomson, C., Phung, N., … Haber, P. S. (2006). Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial. Addiction, 101(10), 1451–1462.Google Scholar

Müller, C. A., Geisel, O., Pelz, P., Higl, V., Krüger, J., Stickel, A., … Heinz, A. (2015). High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial. European Neuropsychopharmacology, 25,1167–1177.Google Scholar

Najavits, L. M., Weiss, R. D., & Liese, B. S. (1996). Group cognitive behavioural therapy for women with PTSD and substance use disorder. Journal of Substance Abuse Treatment, 13, 13–22.Google Scholar

National Institute for Health and Clinical Excellence. (2011). Alcohol dependence and harmful alcohol use (NICE Clinical Guideline 115). London: National Institute for Health and Clinical Excellence.Google Scholar

Nunes, E. V., & Levin, F. R. (2004). Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis. JAMA, 291(15), 1887–1896.Google Scholar

O’Farrell, T. J., Choquette, K. A., Cutter, H. S. G., Brown, E. D., & McCourt, W. F. (1993). Behavioural marital therapy with and without additional couples relapse prevention sessions for alcoholics and their wives. Journal of Studies on Alcohol, 54, 652–666.Google Scholar

O’Farrell, T. J., & Clements, K. (2012). Review of outcome research on marital and family therapy in treatment for alcoholism. Journal of Marital and Family Therapy, 38(1), 122–144.CrossRefGoogle ScholarPubMed

O’Malley, S. S., Corbin, W. R., Leeman, R. F., DeMartini, K. S., Fucito, L. M., Ikomi, J., … Kranzler, H. R. (2015). Reduction of alcohol drinking in young adults by naltrexone: A double-blind, placebo-controlled, randomized clinical trial of efficacy and safety. Journal of Clinical Psychiatry, 76(2), e207–e213.Google Scholar

Oslin, D. W., Leong, S. H., Lynch, K. G., Berrettini, W., O’Brien, C. P., Gordon, A. J., & Rukstalis, M. (2015). Naltrexone vs placebo for the treatment of alcohol dependence: A randomized clinical trial. JAMA Psychiatry, 72(5), 430–437.Google Scholar

Pani, P. P., Trogu, E., Pacini, M., & Maremmani, I. (2014). Anticonvulsants for alcohol dependence. Cochrane Database of Systematic Reviews, CD008544.Google Scholar

Petrakis, I. L., Nich, C., & Ralevski, E. (2006a). Psychotic spectrum disorders and alcohol abuse: A review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram. Schizophrenia Bulletin, 32(4), 644–654.Google Scholar

Petrakis, I. L., Poling, J., Levinson, C., Nich, C., Carroll, K., Rounsaville, B., & VA New England VISN I MIRECC Study Group. (2005). Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biological Psychiatry, 57(10), 1128–1137.Google Scholar

Petrakis, I. L., Poling, J., Levinson, C., Nich, C., Carroll, K., Ralevski, E., & Rounsaville, B. (2006b). Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder. Biological Psychiatry, 60(7), 777–783.Google Scholar

Petrakis, I. L., Ralevski, E., Desai, N., Trevisan, L., Gueorguieva, R., Rounsaville, B., & Krystal, J. H. (2012). Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology, 37(4), 996–1004.Google Scholar

Petrakis, I., Ralevski, E., Nich, C., Levinson, C., Carroll, K., Poling, J., … VA VISN I MIRECC Study Group. (2007). Naltrexone and disulfiram in patients with alcohol dependence and current depression. Journal of Clinical Psychopharmacology, 27(2), 160–165.Google Scholar

Pettinati, H. M., Gastfriend, D. R., Dong, Q., Kranzler, H. R., & O’Malley, S. S. (2009). Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol dependent patients. Alcoholism: Clinical and Experimental Research, 33, 350–356.Google Scholar

Pettinati, H. M., Oslin, D. W., Kampman, K. M., Dundon, W. D., Xie, H., Gallis, T. L., Dackis, C. A., & O’Brien, C. P. (2010). A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. American Journal of Psychiatry, 167(6), 668–675.Google Scholar

Project MATCH Research Group. (1997 a). Matching alcoholism treatments to client heterogeneity: Project MATCH post-treatment drinking outcomes. Journal of Studies on Alcohol, 58, 7–29.Google Scholar

Project MATCH Research Group. (1997 b). Project MATCH secondary a priori hypothesis. Addiction, 92, 1671–1698.Google Scholar

Project MATCH Research Group. (1998). Matching alcoholism treatments to client heterogeneity: Treatment main effects and matching effects on drinking during treatment. Journal of Studies on Alcohol, 59, 631–639.Google Scholar

Raistrick, D., Heather, N., & Godfrey, C. (2006). Review of the effectiveness of treatment for alcohol problems. London: National Treatment Agency for Substance Misuse.Google Scholar

Rogers, C. R. (1957). The necessary and sufficient conditions for therapeutic personality change. Journal of Consulting Psychology, 21, 95–103.Google Scholar

Rohsenhow, D. J., Monti, P., Rubonis, D., Gulliver, S. B., Colby, S. M., Binkoff, J. A., & Abrams, D. B. (2001). Cue exposure with coping skills training and communication skills training for alcohol dependence: 6- and 12-month outcomes. Addiction, 96, 1161–1174.Google Scholar

Rösner, S., Leucht, S., Lehert, P., & Soyka, M. (2008). Acamprosate supports abstinence, naltrexone prevents excessive drinking: Evidence from a meta-analysis with unreported outcomes. Journal of Psychopharmacology, 22(1), 11–23.CrossRefGoogle ScholarPubMed

Rösner, S., Hackl-Herrwerth, A., Leucht, S., Lehert, P., Vecchi, S., & Soyka, M. (2010). Acamprosate for alcohol dependence. Cochrane Database Syst ematic Reviews (9):CD004332.Google Scholar

Shand, F., Gates, J., Fawcett, J., & Mattick, R. (2003). The treatment of alcohol problems: A review of the evidence. Canberra, Australia: Commonwealth Department of Health and Ageing.Google Scholar

Skinner, M. D., Lahmek, P., Pham, H., & Aubin, H. J. (2014). Disulfiram efficacy in the treatment of alcohol dependence: A meta-analysis. PloS One, 9(2), e87366.Google Scholar

Slattery, J., Chick, J., Cochrane, M., Craig, J., Godfrey, C., Macpherson, K.,. & Parrott, S. (2003). Prevention of relapse in alcohol dependence. Glasgow: Health Technology Board for Scotland.Google Scholar

Stade, B. C., Bailey, C., Dzendoletas, D., Sgro, M., Dowswell, T., & Bennett, D. (2009). Psychological and/or educational interventions for reducing alcohol consumption in pregnant women and women planning pregnancy. Cochrane Database of Systematic Reviews, CD004228.Google Scholar

Torrens, M., Fonseca, F., Mateu, G., & Farré, M. (2005). Efficacy of antidepressants in substance use disorders with and without comorbid depression: A systematic review and meta-analysis. Drug and Alcohol Dependence, 78(1), 1–22.Google Scholar

Tripodi, S. J., Bender, K., Litschge, C., & Vaughn, M. G. (2010). Interventions for reducing adolescent alcohol abuse: A meta-analytic review. Archives of Pediatrics & Adolescent Medicine, 164(1), 85–91.Google Scholar

UKATT Research Team. (2005 a). Effectiveness of treatment for alcohol problems: Findings of the randomised UK Alcohol Treatment Trial (UKATT). British Medical Journal, 331, 541–544.Google Scholar

UKATT Research Team. (2005 b). Cost effectiveness of treatment for alcohol problems: Findings of the randomised UK Alcohol Treatment Trial (UKATT). British Medical Journal, 331, 544–547.Google Scholar

van den Brink, W., Aubin, H. J., Bladström, A., Torup, L., Gual, A., & Mann, K. (2013). Efficacy of as-needed nalmefene in alcohol-dependent patients with at least a high drinking risk level: Results from a subgroup analysis of two randomized controlled 6-month studies. Alcohol and Alcoholism, 48(5), 570–578.CrossRefGoogle ScholarPubMed

Verheul, R., Lehert, P., Geerlings, P. J., Koeter, M. W., & van den Brink, W. (2005). Predictors of acamprosate efficacy: Results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients. Psychopharmacology, 178(2–3), 167–173.Google Scholar

Walker, B. M., Zorrilla, E. P., & Koob, G. F. (2011). Systemic κ-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats. Addiction Biology, 16(1), 116–119.Google Scholar

Williams, E. E. (1937). Effects of alcohol on workers with Carbon Disulfide. Journal of the American Medical Association, 109, 1472–1473.Google Scholar

Witkiewitz, K., Bowen, S., Harrop, E. N., Douglas, H., Enkema, M., & Sedgwick, C. (2014). Mindfulness-based treatment to prevent addictive behavior relapse: Theoretical models and hypothesized mechanisms of change. Substance Use & Misuse, 49(5), 513–524.Google Scholar